Novartis | سود عملیاتی



Operating Profit تغییر دادن تاریخ
AbbVie USD 5.72B 1.98B 2025-06
Alcon AG USD 468M 73M 2025-03
Almirall EUR 43.02M 8.82M 2025-06
Amgen USD 2.66B 1.37B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Autolus Therapeutics Ltd -82608000 17.37M 2025-06
Bayer EUR 13M 2.31B 2025-06
Biogen USD 851.8M 540.6M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Fresenius EUR 560M 127M 2025-06
Fresenius Medical Care EUR 431M 100M 2025-06
Galapagos EUR -57027000 101.68M 2025-06
Genmab DKK 360M 172M 2025-06
Gilead Sciences USD 2.7B 467M 2025-06
GlaxoSmithKline GBP 2.02B 193M 2025-06
GRIFOLS EUR 349.54M 80.68M 2025-06
Hikma Pharmaceutical USD 282M 45M 2024-12
J&J USD 6.94B 6.69B 2025-06
Lonza CHF 430M 104M 2024-12
Merck EUR 1.03B 24M 2025-06
Merck USD 6.36B 494M 2025-06
Novartis USD 4.86B 201M 2025-06
Novartis USD 3.4B 193M 2024-12
Novo Nordisk 34.08B 4.71B 2025-06
Orion EUR 104.6M 26.7M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Philips EUR 488M 334M 2025-06
Recordati EUR 149.95M 45.82M 2025-06
Regeneron Pharmaceuticals USD 1.08B 487.8M 2025-06
Roche Holding CHF 4.39B 1.04B 2024-12
Sanofi EUR 1.71B 573M 2025-06
UCB EUR 1B 678M 2024-12


Novartis سود عملیاتی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Aug 2025.